GlassScriptPhysician profile
Khurrum Khan
NPI 1831545912
$19,067.26
in general payments reported to CMS, 2019-2025
33 companies · $1,253 in 2025
The $1,253 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $546 · 2021: $3,881 · 2022: $10K · 2023: $1,597 · 2024: $1,219 · 2025: $1,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,069.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,928.48 | 2020-2025 | Aveir, Assurity, Coroflow |
| Medtronic, INC. | $3,653.24 | 2021-2025 | Abre, Symplicity G3 |
| Boston Scientific Corporation | $1,180.70 | 2019-2025 | Wolverine Coronary Cutting Balloon, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Abiomed | $945.86 | 2021-2025 | Impella |
| Shockwave Medical, INC | $932.71 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $300.78 | 2022-2024 | (Bh4) Igt Devices Undivided |
| Janssen Pharmaceuticals, INC | $233.26 | 2021-2024 | Xarelto |
| Cardiovascular Systems INC. | $159.41 | 2020-2022 | |
| Osprey Medical INC | $158.19 | 2020-2021 | |
| Inari Medical, INC. | $151.57 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $150.00 | 2025 | Torus Stent Graft System, Endocross Device |
| Astrazeneca Pharmaceuticals LP | $139.01 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.68 | 2021-2024 | Lifevest |
| Cardiva Medical, INC. | $122.84 | 2021-2022 | |
| Astellas Pharma US INC | $117.07 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $110.58 | 2024-2025 | Fintepla, Briviact, Nayzilam |
| Amgen INC. | $109.48 | 2022-2025 | Repatha |
| Biosense Webster, INC. | $91.38 | 2025 | Carto 3 |
| Biotronik INC. | $76.96 | 2021 | |
| Pfizer INC. | $63.12 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.16 | 2022 | |
| Argenx US, INC. | $34.20 | 2025 | Vyvgart Hytrulo |
| Atricure, INC. | $33.47 | 2025 | Synergy Ablation System |
| Ossur Americas, INC. | $26.59 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $24.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $22.76 | 2021 | |
| Cmp Pharma, INC. | $21.32 | 2021 | |
| Exact Sciences Corporation | $20.49 | 2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $18.76 | 2025 | Myfembree |
| Lilly USA, LLC | $18.75 | 2025 | Mounjaro, Zepbound |
| Chiesi USA, INC. | $16.48 | 2021 | |
| Abbvie INC. | $14.88 | 2025 | |
| Ge Healthcare | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khurrum Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.